About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ptf1atm1(cre)Hnak
targeted mutation 1, Hassan Nakhai
MGI:3701996
Summary 18 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Notch1tm1Agt/Notch1tm1Agt
Notch2tm1Frad/Notch2tm1Frad
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129 * BALB/cJ MGI:3809249
cn2
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm2Tyj
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129P2/OlaHsd * 129S4/SvJae MGI:5510703
cn3
Krastm4Tyj/Kras+
Raf1tm2Bacc/Raf1tm2Bacc
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129P2/OlaHsd * 129S4/SvJae MGI:5510702
cn4
Krastm4Tyj/Kras+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S4/SvJae MGI:5510701
cn5
Krastm4Tyj/Krastm4Tyj
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S4/SvJae MGI:4818400
cn6
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S4/SvJae * 129S6/SvEvTac MGI:5510696
cn7
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J MGI:3814193
cn8
Diras2em1Gpt/Diras2em1Gpt
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
involves: 129S4/SvJae * C57BL/6 MGI:7738284
cn9
Diras2em1Gpt/Diras2em1Gpt
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S4/SvJae * C57BL/6J * C57BL/6JGpt MGI:7738283
cn10
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
involves: 129S4/SvJae * C57BL/6J * C57BL/6N MGI:7738261
cn11
Gt(ROSA)26Sortm1Sor/?
Ptf1atm1(cre)Hnak/Ptf1atm1(cre)Hnak
involves: 129S4/SvJaeSor MGI:3702510
cn12
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S6/SvEvTac MGI:5510695
cn13
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S6/SvEvTac MGI:5510694
cn14
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S6/SvEvTac * C57BL/6J MGI:3814192
cn15
Ptf1atm1(cre)Hnak/Ptf1a+
Rbpjtm1Rsch/Rbpjtm1Rsch
involves: 129X1/SvJ MGI:3809248
cn16
Relatm1Rsch/Relatm1Rsch
Ptf1atm1(cre)Hnak/?
involves: C57BL/6 MGI:3713700
cn17
Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
involves: C57BL/6 MGI:5510698
cn18
Ptf1atm1(cre)Hnak/Ptf1a+
Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
involves: C57BL/6J * C57BL/6N MGI:7738262


Genotype
MGI:3809249
cn1
Allelic
Composition
Notch1tm1Agt/Notch1tm1Agt
Notch2tm1Frad/Notch2tm1Frad
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129 * BALB/cJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Notch1tm1Agt mutation (0 available); any Notch1 mutation (117 available)
Notch2tm1Frad mutation (0 available); any Notch2 mutation (99 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• at E14.5, the acinar compartment is reduced compared to in wild-type mice

endocrine/exocrine glands
• at E14.5, the acinar compartment is reduced compared to in wild-type mice
• the endocrine epithelium is mildly disrupted
• however, morphology of the islets is normal
• the number of islets is decreased compared to in wild-type mice
• mice exhibit a 25% decrease in the number of proliferating cells compared to in wild-type mice
• at E13.5, pancreatic buds are less branched than in wild-type mice
• at E13.5, pancreatic buds are smaller than controls
• the pancreas is slightly smaller than in wild-type mice at P1




Genotype
MGI:5510703
cn2
Allelic
Composition
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm2Tyj
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (240 available)
Trp53tm2Tyj mutation (4 available); any Trp53 mutation (240 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• however, treatment with a potent and selective oral pan class I PI3K inhibitor (GDC 0941) blocks tumor growth

endocrine/exocrine glands
• however, treatment with a potent and selective oral pan class I PI3K inhibitor (GDC 0941) blocks tumor growth




Genotype
MGI:5510702
cn3
Allelic
Composition
Krastm4Tyj/Kras+
Raf1tm2Bacc/Raf1tm2Bacc
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Raf1tm2Bacc mutation (2 available); any Raf1 mutation (117 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• as in Krastm4Tyj Ptf1atm1(cre)Hnak double heterozygotes

endocrine/exocrine glands
• as in Krastm4Tyj Ptf1atm1(cre)Hnak double heterozygotes




Genotype
MGI:5510701
cn4
Allelic
Composition
Krastm4Tyj/Kras+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Pdpk1tm1Mlw mutation (0 available); any Pdpk1 mutation (138 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• pancreas of older mice exhibit some areas of fatty degeneration
• however, acinar to ductal metaplasia observed in acini from Krastm4Tyj Ptf1atm1(cre)Hnak double heterozygotes is rescued in an in vitro assay

neoplasm
N
• pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma observed in Krastm4Tyj Ptf1atm1(cre)Hnak double heterozygotes is rescued




Genotype
MGI:4818400
cn5
Allelic
Composition
Krastm4Tyj/Krastm4Tyj
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype



Genotype
MGI:5510696
cn6
Allelic
Composition
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S4/SvJae * 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2(Pik3ca*)Dsa mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Pdpk1tm1Mlw mutation (0 available); any Pdpk1 mutation (138 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• mice do not develop acinar to ductal metaplasia

neoplasm
N
• mice do not develop pancreatic intraepithelial neoplasia or pancreatic ductal adenocarcinoma




Genotype
MGI:3814193
cn7
Allelic
Composition
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Tva)Dsa mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• median survival of mice infected with RCASBP(A)-shTP53, which knocks down Trp53 expression, is only 151 days compared to 485 days for controls

neoplasm
• mice infected with RCASBP(A)-shTP53, which knocks down Trp53 expression, display a significantly shorter latency of pancreatic ductal adenocarcinoma development
• all infected mice develop invasive pancreatic ductal adenocarcinoma within 10 months

endocrine/exocrine glands
• mice infected with RCASBP(A)-shTP53, which knocks down Trp53 expression, display a significantly shorter latency of pancreatic ductal adenocarcinoma development
• all infected mice develop invasive pancreatic ductal adenocarcinoma within 10 months




Genotype
MGI:7738284
cn8
Allelic
Composition
Diras2em1Gpt/Diras2em1Gpt
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Diras2em1Gpt mutation (0 available); any Diras2 mutation (20 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Ube2ftm1c(EUCOMM)Hmgu mutation (0 available); any Ube2f mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• relative to mutant mice wild-type for Diras2
• incidence of pancreatic tumors is similar to mutant mice wild-type for both Diras2 and Ube2f but with fewer stage I and more stage II and III tumors

neoplasm
• relative to mutant mice wild-type for Diras2
• incidence of pancreatic tumors is similar to mutant mice wild-type for both Diras2 and Ube2f but with fewer stage I and more stage II and III tumors




Genotype
MGI:7738283
cn9
Allelic
Composition
Diras2em1Gpt/Diras2em1Gpt
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S4/SvJae * C57BL/6J * C57BL/6JGpt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Diras2em1Gpt mutation (0 available); any Diras2 mutation (20 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• more aggressive neoplastic progression with increased population of stage III neoplasia and decreased populations of acinar cells, acinar-to-ductal metaplasia, and stage I neoplasia compared to mutant mice wild-type for Diras2

neoplasm
• more aggressive neoplastic progression with increased population of stage III neoplasia and decreased populations of acinar cells, acinar-to-ductal metaplasia, and stage I neoplasia compared to mutant mice wild-type for Diras2




Genotype
MGI:7738261
cn10
Allelic
Composition
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
Genetic
Background
involves: 129S4/SvJae * C57BL/6J * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Ube2ftm1c(EUCOMM)Hmgu mutation (0 available); any Ube2f mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• relative to mutant mice wild-type for Ube2f indicating improved growth

neoplasm
• decrease in pancreatic intraepithelial neoplasia at all 3 stages relative to mutant mice wild-type for Ube2f at 4, 6, and 9 months of age
• by 12 months of age there is an increase in stage I but decrease in stage II and III lesions in the pancreas indicating a delay in pancreatic tumor progression

endocrine/exocrine glands
• relative to mutant mice wild-type for Ube2f
• decrease in disruption of acinar cell population in cerulein-induced pancreatitis
• fewer infiltrations of leukocytes and neutrophils at 3d after cerulein treatment




Genotype
MGI:3702510
cn11
Allelic
Composition
Gt(ROSA)26Sortm1Sor/?
Ptf1atm1(cre)Hnak/Ptf1atm1(cre)Hnak
Genetic
Background
involves: 129S4/SvJaeSor
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die within about 3 hours of birth

vision/eye
• lack differentiated amacrine cells at E18.5
• almost no GABAergic or glycinergic positive amacrine cells are found in retinal explants cultured for 12 days; however some syntaxin- and calbindin-positive cells do develop indicating retention of a small subpopulation of differentiated amacrine cells
• in retinal explants cultured for 12 days, syntaxin-, PKCalpha- and calbindin-positive cells are disorganized
• at E18.5, beta-gal expressing cells are found scattered in the inner retina, unlike in control mice where these cells are localized in the innermost zone of the neuroblastic layer
• fusion of the ganglion cell layer and the neuroblastic layer results in loss of the inner plexifom layer

nervous system
• lack differentiated amacrine cells at E18.5
• almost no GABAergic or glycinergic positive amacrine cells are found in retinal explants cultured for 12 days; however some syntaxin- and calbindin-positive cells do develop indicating retention of a small subpopulation of differentiated amacrine cells




Genotype
MGI:5510695
cn12
Allelic
Composition
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2(Pik3ca*)Dsa mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Pdpk1tm1Mlw mutation (0 available); any Pdpk1 mutation (138 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• mice do not develop acinar to ductal metaplasia

neoplasm
N
• mice do not develop pancreatic intraepithelial neoplasia or pancreatic ductal adenocarcinoma




Genotype
MGI:5510694
cn13
Allelic
Composition
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2(Pik3ca*)Dsa mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• phenocopies metastatic pancreatic ductal adenocarcinoma that develops in mice expressing with Krastm4Tyj activated in the pancreas
• in all mice as early as 1 month with progression in amount and grade over time
• massive induction of acinar to ductal metaplasia

neoplasm
• in all mice as early as 1 month with progression in amount and grade over time
• pancreatic carcinoma in situ in some mice at 9 months
• phenocopies metastatic pancreatic ductal adenocarcinoma that develops in mice expressing with Krastm4Tyj activated in the pancreas

growth/size/body




Genotype
MGI:3814192
cn14
Allelic
Composition
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Tva)Dsa mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 19 months after infection with RCASBP(A)-KrasG12D retrovirus 3 of 5 mice developed invasive and metastatic pancreatic ductal adenocarcinomas with 2 of the 5 developing liver and lymph node metastases
• all pancreatic ductal adenocarcinomas display a ductal phenotype, an intense desmoplastic stroma and local infiltration
• 9 months after infection with RCASBP(A)-KrasG12D retrovirus 4 of 5 mice developed focal ductal pancreatic lesions that closely resembled human pancreatic intraepithelial neoplasias
• 9 months after infection with RCASBP(A)-KrasG12D retrovirus 4 of 5 mice developed focal ductal pancreatic lesions that closely resembled human pancreatic intraepithelial neoplasias
• 19 months after infection with RCASBP(A)-KrasG12D retrovirus 3 of 5 mice developed invasive and metastatic pancreatic ductal adenocarcinomas with 2 of the 5 developing liver and lymph node metastases
• all pancreatic ductal adenocarcinomas display a ductal phenotype, an intense desmoplastic stroma and local infiltration

endocrine/exocrine glands
• 19 months after infection with RCASBP(A)-KrasG12D retrovirus 3 of 5 mice developed invasive and metastatic pancreatic ductal adenocarcinomas with 2 of the 5 developing liver and lymph node metastases
• all pancreatic ductal adenocarcinomas display a ductal phenotype, an intense desmoplastic stroma and local infiltration
• 9 months after infection with RCASBP(A)-KrasG12D retrovirus 4 of 5 mice developed focal ductal pancreatic lesions that closely resembled human pancreatic intraepithelial neoplasias




Genotype
MGI:3809248
cn15
Allelic
Composition
Ptf1atm1(cre)Hnak/Ptf1a+
Rbpjtm1Rsch/Rbpjtm1Rsch
Genetic
Background
involves: 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Rbpjtm1Rsch mutation (0 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die by 6 to 7 days after birth

digestive/alimentary system
• at E14.5, no acinar cells are detected unlike in wild-type mice
• by E18.5, few acinar cells appear in late embryonic development
• mice exhibit impaired milk digestion

growth/size/body
• moderate at birth

endocrine/exocrine glands
• at birth the pancreas is small and altered compared to in wild-type mice
• unlike in wild-type mice, the duodenal part of the pancreas exhibits weak branching and the splenic part exhibits no branching
• at E14.5, no acinar cells are detected unlike in wild-type mice
• by E18.5, few acinar cells appear in late embryonic development
• at E11.5, mice exhibit an increase in glucagon producing cells
• the number of islets is decreased compared to wild-type mice
• the endocrine epithelium is disrupted with alpha cells not surrounded by beta cells and long rather than circular islet-like structures
• at E13.5, the pancreatic epithelial mass is reduced and pancreatic bud branching is weaker than in wild-type mice
• mice exhibit a 40% decrease in the number of proliferating cells compared to in wild-type mice
• at E11.5, mice exhibit premature differentiation into endocrine cells

cellular
• at E11.5, mice exhibit premature differentiation into endocrine cells




Genotype
MGI:3713700
cn16
Allelic
Composition
Relatm1Rsch/Relatm1Rsch
Ptf1atm1(cre)Hnak/?
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Relatm1Rsch mutation (0 available); any Rela mutation (28 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 1 of 4 mice died 48 hours after induced pancreatitis

homeostasis/metabolism
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, IL-6 levels are increased
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, pancreatic levels of TNF-alpha are increased
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, mice experience panreatitis with increased vascuolizaztion, morphologically apoptotic cells, ghost cells, edema, infiltrate and massive necrosis, increased pancreatic levels of TNF-alpha and IL-6 and lung inflammation characterized by alveolar fluid accumulation and progressive thickening, hyperemia, and neutrophil infiltration of interalveolar tissue
• 1 of 4 mice died 48 hours after induced pancreatitis

immune system
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, mice experience panreatitis with increased vascuolizaztion, morphologically apoptotic cells, ghost cells, edema, infiltrate and massive necrosis
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, IL-6 levels are increased
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, pancreatic levels of TNF-alpha are increased
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, lung inflammation is characterized by alveolar fluid accumulation and progressive thickening, hyperemia, and neutrophil infiltration of interalveolar tissue

endocrine/exocrine glands
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, mice experience panreatitis with increased vascuolizaztion, morphologically apoptotic cells, ghost cells, edema, infiltrate and massive necrosis

respiratory system
• following 8 intraperitoneal injections of cerulein to induce pancreatitis, lung inflammation is characterized by alveolar fluid accumulation and progressive thickening, hyperemia, and neutrophil infiltration of interalveolar tissue




Genotype
MGI:5510698
cn17
Allelic
Composition
Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• mice do not develop acinar to ductal metaplasia

neoplasm
N
• mice do not develop pancreatic intraepithelial neoplasia




Genotype
MGI:7738262
cn18
Allelic
Composition
Ptf1atm1(cre)Hnak/Ptf1a+
Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
Genetic
Background
involves: C57BL/6J * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptf1atm1(cre)Hnak mutation (1 available); any Ptf1a mutation (31 available)
Ube2ftm1c(EUCOMM)Hmgu mutation (0 available); any Ube2f mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• no detectable change in cerulein-induced pancreatitis





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory